ERFSF News and Press, Eurofins Scientific S.E. From 04/26/23

2023-04-26 03:08:37 ET Eurofins Scientific press release ( OTCPK:ERFSF ): Q1 Revenue of €1.57B -10.5% vs Q1 2022 Eurofins is confirming its objectives for FY 2023 to FY 2027 as announced at the FY 2022 results presentation on 01 March 2023: For FY2023 Rev...

2023-04-13 02:30:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

2023-03-31 12:13:40 ET Summary We present an overview of the testing, inspection, and certification (TIC) market. We highlight the different strategies that have been pursued by the main 4 players over time. Our initial conclusion is that there is much to like about this parti...

Eurofins Scientific SE (ERFSF) Q4 2022 Results Conference Call March 01, 2023 09:00 AM ET Company Participants Dr. Gilles Martin - Chairman and Chief Executive Officer Laurent Lebras - Chief Financial Officer Conference Call Participants Suhasini Varanasi - Gol...

Summary Eurofins is a large life sciences company, but its COVID tailwinds are coming to an end. Apparently the market is surprised by this. I am not. The current share price weakness offers an excellent opportunity for investors with a 5-year investment horizon. Eurofins' 2027 ...

Summary Giverny Capital Asset Management, LLC is a partnership between Giverny Capital of Montreal and David Poppe, the former president and chief executive officer of Ruane, Cunniff & Goldfarb, LLC. For the fourth quarter of 2022, Giverny Capital Asset Management’s model por...

Summary Ruane, Cunniff, & Goldfarb’s 13F portfolio value decreased from $6.73B to $6.40B this quarter. The number of positions increased from 31 to 32. They dropped Wayfair and decreased UnitedHealth, Elevance Health, and Netflix. The top three positions are Charles Schwa...

Highly sensitive ddPCR analytical tool helps identify rapidly increasing SARS-CoV-2 Variant of Concern, XBB.1.5, in wastewater samples domestically and internationally, expanding the comprehensive SARS-CoV-2 wastewater monitoring platform of the Eurofins network Eurofins Environment T...

Eurofins Viracor ExPeCT™ CAR-T multiplexed quantitative real-time PCR (qPCR) assay provides a powerful diagnostic tool to monitor and optimise CAR-T therapy involving patients with pre-B cell acute lymphoblastic leukemia and B cell lymphomas Eurofins (Paris:ERF): Eu...

Summary Sequoia Fund's investment objective is long-term growth of capital. In pursuing this objective, it focuses on investing in equity securities that the advisor believes are undervalued at the time of purchase and have the potential for growth. Sequoia Fund returned -30.52%1 in 202...